News

Brevel Expands Seed Round to US$25 Million Through Warrant Exercise

Microalgae protein innovator paves the path to cost parity with dual-tech processes KIRYAT GAT, Israel, March 24, 2025 /PRNewswire/ -- Climate…

9 months ago

InstantGMP PRO™ Now Available in Spanish, Expanding Compliance Solutions for Global Manufacturers

CARY, N.C., March 24, 2025 /PRNewswire/ -- InstantGMP™, a leading provider of electronic batch record (EBR), manufacturing execution system (MES),…

9 months ago

Advanced Medical Balloons announces its new hygh-tec Odor Solution™ product, broadening its catheter portfolio

hygh-tec Odor Solution™ will be launched in Q2 2025FDA clearance and MDR certification already securedFirst generation hygh-tec™ catheter rapidly achieved more than…

9 months ago

Survey Projects High Turnover Rates Among Healthcare Executives in 2025

46% Plan to Leave Their Organizations in the Next 12 MonthsDALLAS, March 24, 2025 (GLOBE NEWSWIRE) -- Close to half…

9 months ago

PharmAla Contracts with Partner to Act as US Distributor

TORONTO, March 24, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology…

9 months ago

PathAI Expands AISight® Digital Pathology Adoption with Four New Laboratory Partners

BOSTON, March 24, 2025 (GLOBE NEWSWIRE) -- PathAI, a global leader in AI-powered pathology, is pleased to announce that Annapath…

9 months ago

Surrozen Announces an Oversubscribed $175 Million Private Placement of Securities to Focus on Selective Wnt Mimetic Therapeutics to Treat Serious Eye Diseases   

Company prioritizes ophthalmology pipeline programs with potential to provide new or improved treatment options in multiple severe and disabling eye…

9 months ago

Can-Fite Initiates Pivotal Phase 3 Psoriasis Study of its Oral Drug Piclidenoson with FDA & EMA-Approved Protocol

The psoriasis market is estimated at $30 Billion by 2030 and has shifted significantly to oral drugs Ramat Gan, Israel,…

9 months ago

Onconetix Announces Successful Clinical Validation of its Innovative Prostate Cancer Test Proclarix in a Danish cohort

CINCINNATI, March 24, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc., (Nasdaq: ONCO) ("Onconetix" or the “Company”), (formerly Blue Water Biotech, Inc.…

9 months ago

Journey Medical Corporation Launches Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules, 10 mg immediate release and 30 mg extended release) for the Treatment of Rosacea

Initial distribution of Emrosi to pharmacies ongoing First prescriptions of Emrosi filled SCOTTSDALE, Ariz., March 24, 2025 (GLOBE NEWSWIRE) --…

9 months ago